J P Cleutjens
Overview
Explore the profile of J P Cleutjens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1963
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolbach D, Hamulyak K, Prins M, Neumann H, Cleutjens J
Vasa
. 2004 Apr;
33(1):19-24.
PMID: 15061043
Background: Impaired microcirculation in chronic venous insufficiency leads to chronic inflammation and dystrophic changes of the skin, and finally to leg ulceration. The purpose of this study was to investigate...
2.
Dhore C, Cleutjens J, Lutgens E, Cleutjens K, Geusens P, Kitslaar P, et al.
Arterioscler Thromb Vasc Biol
. 2001 Dec;
21(12):1998-2003.
PMID: 11742876
In the present study, we examined the expression of regulators of bone formation and osteoclastogenesis in human atherosclerosis because accumulating evidence suggests that atherosclerotic calcification shares features with bone calcification....
3.
Spronk H, Soute B, Schurgers L, Cleutjens J, Thijssen H, De Mey J, et al.
Biochem Biophys Res Commun
. 2001 Nov;
289(2):485-90.
PMID: 11716499
Vitamin K-dependent matrix Gla protein (MGP) has been suggested to play a role in the inhibition of soft-tissue calcification. Here we report the expression of recombinant prokaryotic MGP as part...
4.
Blankesteijn W, Creemers E, Lutgens E, Cleutjens J, Daemen M, Smits J
Acta Physiol Scand
. 2001 Oct;
173(1):75-82.
PMID: 11678729
Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the...
5.
van Eickels M, Grohe C, Cleutjens J, Janssen B, Wellens H, Doevendans P
Circulation
. 2001 Sep;
104(12):1419-23.
PMID: 11560859
Background: Cardiac hypertrophy is an independent risk factor for cardiovascular morbidity and mortality in men and in women. Epidemiological studies indicate that estrogen replacement therapy is cardioprotective; the mechanisms involved...
6.
Creemers E, Cleutjens J, Smits J, Daemen M
Circ Res
. 2001 Aug;
89(3):201-10.
PMID: 11485970
Increased activity of matrix metalloproteinases (MMPs) has been implicated in numerous disease processes, including tumor growth and metastasis, arthritis, and periodontal disease. It is now becoming increasingly clear that extracellular...
7.
Schurgers L, Dissel P, Spronk H, Soute B, Dhore C, Cleutjens J, et al.
Z Kardiol
. 2001 May;
90 Suppl 3:57-63.
PMID: 11374034
Objectives: To provide a rational basis for recommended daily allowances (RDA) of dietary phylloquinone (vitamin K1) and menaquinone (vitamin K2) intake that adequately supply extrahepatic (notably vascular) tissue requirements. Background:...
8.
van Gijn M, Snel F, Cleutjens J, Smits J, Blankesteijn W
Exp Cell Res
. 2001 Apr;
265(1):46-53.
PMID: 11281642
Frizzled (fz) functions as a 7-transmembrane receptor in the Frizzled-Dishevelled signal transduction cascade. It is involved in architectural control of development in species as divergent as Drosophila and vertebrates. Regulation...
9.
Sandmann S, Claas R, Cleutjens J, Daemen M, Unger T
J Cardiovasc Pharmacol
. 2001 Jan;
37(1):64-77.
PMID: 11152376
Calcium channel antagonists (CCAs) have been proposed to prevent cardiac events after myocardial infarction (MI). However, unwanted effects, such as negative inotropy, limit their use in many cases. The aim...
10.
Cleutjens J, Blankesteijn W, Daemen M, Smits J
Cardiovasc Res
. 2000 Feb;
44(2):232-41.
PMID: 10690298
No abstract available.